Record ID | marc_loc_updates/v37.i25.records.utf8:29044306:2552 |
Source | Library of Congress |
Download Link | /show-records/marc_loc_updates/v37.i25.records.utf8:29044306:2552?format=raw |
LEADER: 02552cam a22003494a 4500
001 2007011326
003 DLC
005 20090617124310.0
008 070316s2007 njua b 001 0 eng
010 $a 2007011326
020 $a9780470118795 (cloth)
035 $a(DNLM)101302137
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aRM411$b.C66 2008
245 00 $aCombating the threat of pandemic influenza :$bdrug discovery approaches /$cedited by Paul F. Torrence.
260 $aHoboken, N.J. :$bJohn Wiley & Sons,$cc2007.
300 $axiii, 279 p. :$bill. ;$c25 cm.
504 $aIncludes bibliographical references and index.
505 0 $aExisting influenza antivirals : the mechanisms of action and potential in the face of avial influenza / Erik De Clercq -- Development of high-throughput screening assays for influenza / Diana L. Noah, E. Lucile White, and James W. Noah -- Mechanisms of IFN resistance by influenza virus / Heather J. Ezelle and Bret A. Hassel -- Broadly effective anti-respiratory virus agents / Shiro Shigeta -- Current status on development of nucleic acid-based antiviral drugs against influenza virus infection / Jonathan P. Wong ... [et al.] -- Antiviral RNA interferencei strategies targeting influenza virus and other respiratory viruses / Joost Haasnoot and Ben Berkhout -- Promising antiviral glyco-molecules from edible algae / Toshimitsu Hayashi ... [et al.] -- Rational design of an anti-adhesion drug for influenza / Nicolai V. Bovin and Alexandra S. Gambaryan -- Understanding influenza neuraminidase inhibitors using quantitative structure? Activity relationship (QSAR) models / Rajeshwar P. Verma and Corwin Hansch -- Peptide inhibitors targeting virus-cell fusion in Class 1 enveloped viruses / George F. Gao -- Novel approaches to influenza therapeutics / Laura M. Aschenbrenner ... [et a].
650 0 $aAntiviral agents.
650 0 $aInfluenza$xChemotherapy.
650 12 $aInfluenza, Human$xdrug therapy.
650 12 $aInfluenza, Human$xprevention & control.
650 22 $aAntiviral Agents$xtherapeutic use.
650 22 $aDisease Outbreaks$xprevention & control.
650 22 $aDrug Design.
650 22 $aInfluenza Vaccines$xtherapeutic use.
700 1 $aTorrence, Paul F.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0713/2007011326.html
856 42 $3Contributor biographical information$uhttp://www.loc.gov/catdir/enhancements/fy0805/2007011326-b.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0805/2007011326-d.html